Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-dose versus single-dose dexamethasone for reducing rhinoplasty-related bleeding and postoperative swelling
IRCT2014011316195N1Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- May 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexamethasone in rhinoplasty (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Intraoperative bleeding, Blood pressure and 3 more. Started May 2013; status: completed.
02
Drugs
dexamethasone
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT2014011316195N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014011316195N1.